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Abstract: Individuals undergoing treatment for cancer can experience changes in taste or smell that
are often assumed to affect constructs related to food behavior, although this relationship is rarely
measured directly. To ascertain the extent to which measured changes in taste and smell during
and after cancer treatment affect food behavior, we conducted a scoping review and completed a
comparative analysis for studies that met our criteria, which were: they directly measured cancer
patients’ (a) psychophysical response to taste and/or olfactory stimuli, and (b) food behavior (including
food enjoyment, food preference, dietary intake) in people affected by cancer. Eleven studies met
these criteria and were included in the review. All 11 studies evaluated taste and five also measured
smell. A comparative analysis exploring taste and food behavior shows that a reduced sweet taste
function (decreased sensitivity) was associated with a reduced intake of a variety of different macro
and micro nutrients, reduced appetite, and overall lower energy intake. One out of six studies
that measured smell and food measured observed changes in olfactory function following cancer
treatment. There were no significant relationships reported between olfactory measures and food
behavior. Taste changes that arise from cancer treatment appear to have a direct effect on food
behavior, although there is a need for more research using standardized measures and larger sample
sizes. A better understanding of taste alterations and their implications for dietary intake and food
enjoyment will support optimal nutritional health by identifying strategies to help patients eat well
during and after cancer treatment.
Keywords: chemotherapy; chemosensory loss; dysgeusia; chemosensory dysfunction; chemosensory
perception; flavor; taste; smell; appetite; oncology; dietician
1. Introduction
According to the National Cancer Institute, in the United States, one in three adults are diagnosed
with cancer (based on 2013–2015 data) [1]. The decline in the cancer death rate (26% reduction between
1991 and 2015) [1], is resulting in a larger number of individuals surviving cancer, with the number of
cancer survivors expected to rise to 20.3 million by 2026 [2].
Many people receiving cancer treatment complain of changes to their taste and smell functions,
presenting as various manifestations, though routinely described as a loss or alteration of perception [3].
Prevalence of self-reported taste problems among cancer patients ranges from 12% to 84% [4–6].
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Taste and smell play an important role in food behavior, so changes in taste or smell perception
may negatively influence eating behavior [7–9]. “Food behavior” is an inclusive term to capture any
type of food-related behavior that might have real-world significance for patients’ overall nutritional
health [10], such as the desire to eat, food preferences, and food intake, in ways that lead to weight
change and poor quality of life [11–14]. Several studies have investigated cancer-related changes in
chemosensation (i.e., taste and smell) or food-related behavior; however, it is rare for a study to use
both measures.
There is a wide variability in the prevalence rates for reported taste function (12% to 84% [4–6]).
There are both clinical and demographic patient characteristics that could have an impact on taste
function. The various treatment regimens and cancer types studied, the different methods used to
evaluate taste [3,15,16], how “taste” was defined in these studies, and the end points examined, all
effect the study results. For example, some authors describe “taste” as a study end point but do not
assess taste per se. Other patient characteristics, such as smoking history, alcohol abuse, and genetics,
have all known to play a role in individual variability in taste perception.
This review critically evaluates research published from 1982 to 2018 that psychophysically
measured taste and smell function and assessed some aspect of food behavior (e.g., appetite, dietary
intake, and preference). We reviewed studies that used objective measures of taste and smell function
(i.e., using psychophysical methods), as opposed to self-reported changes in taste or smell. The rationale
for this selection strategy was based on the observation that patients often do not distinguish between
taste and smell or confuse sensory constructs with hedonic constructs, such as appetite or food
enjoyment, so self-reported changes are often unrelated to objectively measured taste changes [17,18].
For example, a food may taste the same as it always did but that taste is no longer enjoyed.
2. Methods
2.1. Study Selection
Our focus on taste and food behavior in people with cancer posed several challenges in
systematically reviewing the literature because no standard search terms returned appropriate
studies. We therefore took a two-pronged approach: First, we started with the most current published
papers and traced citations back to 1961, the earliest paper reporting on taste psychophysics of cancer
patients. This paper from 1961 served as the starting point of the period covered by the review.
Second, we included the broad terms “taste” and “smell” (i.e., taste, smell, olfaction, chemosensory),
“objective evaluation” (i.e., threshold, detection threshold, recognition threshold, sensitivity, intensity,
identification), “food behavior” (i.e., dietary food intake, food preference, food behavior, appetite,
food liking), “human,” and “cancer” or “chemotherapy” and read the abstracts to identify relevant
papers. Papers were removed that did not use methods that objectively measured taste and/or smell
function or did not include measures of food behavior. Papers were not excluded based on study
design (e.g., cohort or longitudinal), cancer diagnosis, treatment type, or time since cancer diagnosis or
treatment. Papers that met the above criteria were removed if articles were not written in English,
included children (<18 years old), or were not original research publications. Database searches were
carried out in PubMed, Web of Science, Google Scholar, and from the University of Pennsylvania and
University of Massachusetts Libraries. Two authors reviewed the abstracts of the unique original
research articles from the resulting literature searches (n = 44), and additional articles were identified
through reference searches and searches of similar articles, with 11 articles fulfilling the criteria.
2.2. Data Extraction
Data from selected articles were manually extracted, including sample size, experimental design,
methods of sensory measurement, food behavior metrics, and summary statistical statistics.
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2.3. Statistical Approach for Comparative Analysis
Three of the eleven articles were included in the comparative analysis due to eight of the eleven
articles having insufficient data available for extraction. Means and standard deviations of the
comparison groups, test statistics, and other metrics for the comparative analysis were obtained where
possible. We calculated the effect sizes with the d statistic using previous methods [19].
3. Results
3.1. Study Characteristics and Design
The characteristics of the 11 studies included in the review and comparative analysis are
summarized in Table 1. The studies included had a combined total of 578 participants, comprising
380 people with cancer and 198 controls. Five studies enrolled patients with more than one cancer type
and six enrolled patients with a single cancer type. Cancer diagnoses varied across studies, including
breast, esophagogastric, lung, ovarian, prostate, colon, multiple myeloma, lymphoma, and testicular
cancer, with one study not reporting a cancer type.
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Table 1. Summary of studies using direct measures of taste and/or smell and measures of food behavior.
Study Subjects and Cancer
Type (n)
Study Design Chemosensory Evaluation Food Behavior Evaluation Outcome




Breast (n = 14) or
colon (n = 15); controls
(n = 28)
Prospective, longitudinal
cohort study; baseline and




Taste: DT and RT










Prior to treatment, there was a
significant correlation between
increased sucrose RT (decreased
sensitivity) with reduced appetite











acid, tonic water with
urea (five conc. of each)
Taste: Intensity and






24-h dietary recall Higher ratings for salt intensity




Breast (n = 4), lung (n
= 16), ovarian (n = 11)
Prospective, longitudinal;




µA) using a gustometer
Taste: DT Dietary intake 3-day food record No relationship between taste or
smell DT and food intake





type (n = 22); controls
(n = 16)
Cross-sectional cohort
study; visit not specified







intake for one meal on
three different days






type (n = 30); controls
(n = 30)
Cross-sectional cohort




Taste: DT and RT using
whole-mouth stimuli
Dietary intake SNUT food frequency
questionnaire
Patients with higher sucrose DT
consumed less protein,
carbohydrate, zinc, and overall
calories; patients with higher urea
RT consumed less protein,




Breast (n = 52) Prospective longitudinal;
visits: baseline, beginning,
middle, and late in third
cycle, beginning of last








sensitivity of taste using
whole-mouth stimuli
Dietary intake Food frequency
questionnaire
Deterioration in identification of
all five taste qualities correlated
with reduced energy intake
IJpma et al.,
2016 [18]
Testicular (n = 50);
controls (n = 48)
Cross-sectional cohort;














taste/smell scores and food
preference or dietary intake
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Table 1. Cont.
Study Subjects and Cancer
Type (n)
Study Design Chemosensory Evaluation Food Behavior Evaluation Outcome
Stimuli Evaluation Food Aspects Method(s)
Turcott et al.,
2016 [26]
Lung (n = 40) Prospective longitudinal;









Increase in sweetness sensitivity
(i.e., lower DT from baseline)
associated with decreased intake
of protein, fat, and iron
IJpma et al.,
2017 [27]
Testicular (n = 21);
controls (n = 48)
Cross-sectional and
prospective longitudinal;
visits: baseline, before and
after cycles 1 and 2, end of
treatment, 7 and 12 months













taste/smell scores with food
preferences or dietary intake











visits at baseline and before
start of third cycle






Food preferences MFPRT rating No relationship between




Taste: RT using taste
strips
de Vries et al.,
2018 [17]
Breast (n = 28);
controls (n = 28)
Prospective longitudinal;
visits at baseline, during
treatment, and 1–3 weeks





Taste: RT using taste
strips Food preferences MFPRT rating
No relationship between
taste/smell and food preferences;
no significant changes in ranking






samples in order of
liking)






* ISO 3972:2011: International Organization for Standardization—method of investigating sensitivity of taste. DT—taste or odor detection threshold; MFPRT—macronutrient and food
preference rating task (rating of food pictures); RT—taste or odor recognition threshold; SNUT—nutritional assessment system habits and nutrient intake (Spanish); conc.—concentration.
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3.2. Methods of Taste and Smell Assessment
A variety of objective measures were used to evaluate taste and smell perception. For taste,
procedures included detection threshold (DT) and recognition threshold (RT). DT is the lowest
concentration that a taste stimulus can be detected compared to the background (i.e., different than
water), with RT referring to the lowest concentration a specific taste can be recognized (e.g., bitter).
Other taste methods included taste identification tasks evaluating the suprathreshold stimuli (e.g.,
International Organization for Standardization (ISO) 3972:2011) intensity rating of suprathreshold
stimuli (concentration above DT), and ranking tasks. Of note, the detection threshold occurs at a
lower concentration than the recognition threshold. Most studies reported stimuli being presented
at room temperature with participants having time between stimuli where water was available for
rinsing. The studies also differed in the way investigators presented smell and taste stimuli to subjects.
For taste, stimuli were presented to either the whole mouth (whole-mouth rinses, sprays) or only parts
of the mouth (filter paper disks, taste strips). For smell, most of the studies used Sniffin’ Sticks (a set of
pen-like devices that dispense an odor) to make three measures of olfaction function: identification,
sensitivity (DT), and discrimination [29]. Table 2 summarizes the methods used to evaluate taste and
smell. For a general review of methods evaluating taste and smell function in oncology populations, see
References [30–33]; for more methodological detail, see References [34,35]; and for clinical applications
for dietitians, see Boltong and Campbell [36].
A variety of different methods were used to assess food behavior across studies. Eight studies
included measures of dietary intake, assessed using either a dietary recall (n = 2), a food frequency
questionnaire (n = 5), or a 3-day weighed food technique (n = 1). Participants answered questions
regarding symptoms related to appetite (n = 5); however, only two studies analyzed the relationship
between chemosensory measures and appetite. Four studies measured food preferences using responses
to food pictures with different macronutrient content.
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Table 2. Methods used to evaluate taste and smell function.
Method Task Stimuli Studies
Taste
Recognition threshold (RT) Lowest concentration a taste can be recognized Taste strips, whole-mouth solutions, or oral drops [17,18,20,24,26–28]
Detection threshold (DT) Lowest concentration something different from water is detected Taste strips, whole-mouth solutions, or oral drops [20,23,24,26]
Identification Identify tastes from a single suprathreshold concentration Whole-mouth solution [25]
Intensity Rating on a 10-cm analog scale labeled from “no (taste sensation)” to“extremely (taste sensation)”. Beverages spiked with tastant [21]
Liking Rating on a 10-cm analog scale labeled from “dislike extremely” to“like extremely” Beverages spiked with tastant [21]
Electrogustometry Lowest detected electrical stimuli (µA) (DT) Anodal current via gustometer [22]
Preference Rank samples in order of liking Beverages spiked with tastants at fiveconcentrations [17]
Smell
DT Lowest concentration detected Pyridine or n-butanol (squeeze bottles or Sniffin’Sticks) [17,18,22,28]
Discrimination From three odors, select the odor that is different from two otheridentical odors (16 triplets presented) Sniffin’ Sticks [17,18,28]
Identification Identify the odor from a choice of four options (16 common odors) Sniffin’ Sticks [17,18,28]
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3.3. Impact of Taste Changes on Food Intake and Preferences
When comparing the experimental results between taste and food behavior for each type of study
design, i.e., cross-sectional and prospective longitudinal, the results were mixed. Of the cross-sectional
cohort studies (including one combined cross-sectional and longitudinal study), several reported a
significant relationship between taste function and food behaviors. Investigators reported that cancer
patients with a loss of appetite were more likely to prefer lower sweetness levels and a reduced intake
of sweet foods compared with patients without a reduced appetite [21]. In another study, changes
in bitter DT correlated with the avoidance of meat, chocolate, and tea [21]. In a third study, changes
in bitter DT correlated with the avoidance of meat, chocolate, and tea; however, the direction (i.e.,
increased or decreased bitter sensitivity) was not reported [23]. In a fourth study, patients with a
higher sucrose DT consumed less protein, carbohydrate, zinc, and fewer calories. In the same study,
patients with a higher urea RT reported consuming fewer calories and less protein, carbohydrate, and
fat. Sucrose and urea thresholds were also associated with energy intake: a greater percentage of
patients who did not meet energy requirements had thresholds above the median for sucrose (DT and
RT) and urea (RT) [24], meaning they found it harder to recognize sweet and bitter tastes. The one
cross-sectional cohort study did not report a significant relationship between taste function and food
behavior in those who had cancer but were in remission and no longer undergoing treatment (cancer
survivors; 1–7 years post-treatment), even though changes in taste function were apparent in this
group [18].
Among the seven prospective longitudinal studies (including one cross-sectional longitudinal
study using a combined approach), three reported a significant relationship between taste and food
behavior. In one of these three studies, the reduced ability to identify taste solutions was associated
with decreased energy intake during the beginning of the third chemotherapy treatment cycle [25].
In a second study, patients who became more sensitive to sucrose between the start of chemotherapy
and after two cycles of chemotherapy consumed fewer grams of protein, animal protein, fat, and
iron compared to those who became less sensitive to sucrose [26]. The third study also found a
relationship between sweet sensitivity and food behavior, reporting that decreased sucrose sensitivity
was associated with reduced appetite prior to treatment [20].
Of the four prospective longitudinal studies that found no taste effects on food behavior, one
showed that changes in sensitivity (as measured by the ability to detect electrical stimulation of the
tongue) was not associated with changes in chemotherapy patients’ protein or energy intake [22].
In two studies, recognition thresholds did not correlate with food preferences [28] or with the liking of
macronutrient categories [17]. The fourth study measured recognition thresholds and collected data
on food frequency intake and food preferences but did not report on associations between objective
taste and food measures [27].
We computed effect sizes from the studies listed in Table 1. Where possible, we computed these
values and report them as d (standardized mean difference; Table 3) to assess the magnitude of taste
changes, allowing for the comparison of findings across studies. However, 5 of the 11 studies reported
no significant effects, and 3 of the 6 studies with significant effects reported too little information to
allow us to compute effect sizes. Therefore, only three of the studies were included in the effect size
calculations, and thus conclusions should be drawn cautiously. However, the effect sizes revealed
that sweet taste has the most empirical evidence for involvement with food behavior, with greater
evidence supporting this link. There was some but limited evidence that bitter taste was involved with
measures of nutrient intake. Almost all studies measured taste changes for four taste qualities, sweet
(n = 10), sour (n = 8), bitter (n = 10), and salty (n = 8), with fewer reporting responses to umami (n = 3);
but positive results and reportable effect sizes were mostly for sweet taste.
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Table 3. Effect sizes for taste – difference in food intake in cancer patients.
Taste Food-Related Intake
a or Change in Intake b in
Patients with Low DT (Mean ± SD).
Intake a or Change in Intake b in
Patients with High DT (Mean ± SD).
Effect
d (95% CI) Reference
Sweet Zinc (mg/day) 17 ± 7 a 9.6 ± 4.5 a 1.18 (0.41, 1.96) Sánchez-Lara, 2010 [24]
Sweet Fat (g/day) +27.39 b −15.1 b 0.97 (0.31, 1.62) Turcott, 2016 [26]
Sweet Carbohydrate (g/day) 240 ± 84 a 167 ± 81 a 0.88 (0.13, 1.63) Sánchez-Lara, 2010 [24]
Sweet Animal protein (g/day) +18.6 b −15.1 b 0.86 (0.21, 1.51) Turcott, 2016 [26]
Sweet Protein (g/day) +30.8 b −7.9 b 0.81 (0.16, 1.45) Turcott, 2016 [26]
Sweet Calories (kcal/day) 1970 ± 658 a 1450 ± 833 a 0.69 (−0.04, 1.43) Sánchez-Lara, 2010 [24]
Sweet Iron (mg/day) +8.4 b −1.11 b 0.65 (0.01, 1.29) Turcott, 2016 [26]
Sweet Appetite * 0.59 (0.00, 1.18) Carson, 1997 [20]
Sweet Protein (g/day) 74 ± 45 a 53 ± 32 a 0.54 (−0.19, 1.27) Sánchez-Lara, 2010 [24]
Bitter Calories/day 2124 ± 812 a 1493 ± 452 a 0.96 (0.20, 1.72) Sánchez-Lara, 2010 [24]
Bitter Carbohydrate (g/day) 254 ± 98 a 182 ± 58 a 0.89 (0.14, 1.64) Sánchez-Lara, 2010 [24]
Bitter Fat (g/day) 87 ± 38 a 62 ± 22 a 0.81 (0.06, 1.55) Sánchez-Lara, 2010 [24]
Bitter Protein (g/day) 83 ± 53 a 52 ± 17 a 0.79 (0.04, 1.53) Sánchez-Lara, 2010 [24]
Effect size d represents the standardized difference of means in food intake, calculated based on mean, standard deviation (SD), p-value, and sample size provided in the literature, between
patients with a low/decreased DT and patients with high/increased DT. CI—95% confidence interval. a Mean intake in patients with low DT. b Change in the mean intake in patients with a
decreased DT. * The study only reported the number of patients with increased or decreased appetite after chemotherapy and the significance (p-value) of the difference. “+” denotes an
increase in intake.
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3.4. Impact of Smell Changes on Food Intake and Preferences
Five studies measured smell function; three of the five studies reported no significant change among
subjects affected by cancer [18,22,28]. One longitudinal study reported significant differences (poorer
smell function) for overall olfactory scores and for threshold olfactory scores (but not discrimination or
identification tasks) during chemotherapy compared with controls [17]. A prospective cohort study of
testicular cancer patients reported lower smell thresholds (greater smell sensitivity) compared with
controls at baseline, with no differences at any other time point (through 1-year post-treatment) [27].
Another longitudinal study reported just under 50% (13 of 27) of patients had changed smell detection
thresholds (compared to baseline): almost equal numbers of participants experienced increased
sensitivity (n = 6) and decreased sensitivity (n = 7) [22]; no other analysis was reported. No comparative
analysis was performed as none of these studies report an instance where smell alterations were
significantly related to any measures of food behaviors.
4. Discussion
4.1. Taste but Not Smell May Influence Food Intake and Enjoyment
The studies reviewed here suggest that cancer patients may suffer from reduced food intake
and appetite, which are associated with alterations in taste perception. Specifically, reduced taste
perception may result in a decreased intake of fat and protein, leading to an overall decrease in energy
consumption (Table 3). These data suggest that patients suffering from reduced taste sensitivity (i.e.,
higher DT) experience greater incidences of food avoidance. Among the 11 research articles reviewed,
six reported no significant relationship between measures of taste (or smell) and food-related behaviors;
none of which supported a relationship between smell function and food behavior.
4.2. The Special Role of Sweet Taste Changes and Food Behavior in Cancer Patients
We performed a comparative analysis and learned that changes in sweet and, to a lesser extent,
bitter perception were more common than changes to salt or sour perception in cancer patients, and
that these changes in sweet taste perception were often tied to differences in food behaviors (Table 3).
The effect sizes, reported in Table 3, allow for the comparison across the studies reporting a significant
relationship between taste and food behavior. The greatest effect size reported was between sweet
sensitivity and zinc intake, with individuals having a greater sensitivity for sweetness (i.e., low DT)
associated with consuming more zinc, compared to those with a lower sensitivity for sweetness (i.e.,
high DT). For bitterness, the highest effect size was observed for the daily consumption of calories, with
individuals with a higher DT (lower sensitivity) consuming on average 631 fewer calories compared to
individuals with a lower DT (greater sensitivity). Reduced sweet taste function (decreased sensitivity)
was associated with a reduced intake of a variety of different macro and micro nutrients, reduced
appetite, and overall lower energy intake. This suggests that reduced taste function, specifically for
sweetness, reduces patient’s food intake.
There are a few mechanisms in which cancer treatment may affect taste and ultimately food
behavior. It is plausible that sweet taste receptors or cells are more vulnerable to cancer treatment or
that neural response to sweet ligands is altered as a result of cancer treatment. Another consideration
is that taste receptors are also expressed in the gut [37] and may be affected in a similar mechanism as
oral taste cells during chemotherapy treatment. Therefore, changes in food behavior may be a result of
gastrointestinal symptoms that co-occur with taste alterations [38,39]. While caution is warranted in
drawing conclusions from this comparative analysis because of the small number of studies, it is clear
that these perceptual changes warrant more study.
Taste and smell loss related to cancer treatment is thought to arise as a result of the cancer
treatment [40]; yet individuals may experience taste and smell changes prior to treatment as a result of
cancer [32]. Each type of cancer treatment may affect taste and smell through different mechanisms [16].
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For example, taste loss during chemotherapy may be due to the disruption of taste cell renewal [41,42],
whereas surgery in the oral cavity could damage chemosensory nerves [43].
4.3. Contrasting Study Designs, Patient Populations, and Methodologies
Cancer treatment is continually making advancements, so as technology and precision medicine
advances, toxicities may differ. For example, in the treatment of head and neck cancers, proton
radiation has a smaller radiation field, and thus may better preserve gustatory tissue when compared
to conventional photon radiation treatment [44]. While it is likely that treatment characteristics and
cancer diagnosis may differentially effect taste perception, conclusions cannot be drawn here about the
effects of specific treatments on taste and food behavior because of both the diversity of treatments and
the limited treatment information provided. Other aspects that could explain the conflicting results
are the mix of study designs (see Table 1) and patient population. Diverse patient populations were
used across studies, with six studies studied a single cancer type, three studies involved patients
from two or more cancer type sub groups, and two studies did not disclose cancer diagnosis. Clinical
and demographic characteristics, such as gender, age, smoking history, upper airway infections, and
drug use, among other factors, are known to impact chemosensory function; however, these data
were reported infrequently and could have had a significant impact on the study outcomes and their
interpretations. Moreover, occurrence and severity of treatment-related symptoms, such as dysphagia,
dry mouth, and nausea, among others, can negatively impact food behavior [36]. More work is
needed to fully understand the implications of co-occurrence of these symptoms on food behavior
and overall nutrition. Data and analyses were reported for the study population, regardless of the
number of treatment types or cancer diagnoses, making it difficult to conduct a meaningful analysis to
examine these clinical characteristics and their association with or influence on taste alterations and
food behavior.
As summarized in Table 2, different methods were used to evaluate chemosensory function,
which included variations in the taste stimulus delivery method. The authors of several studies did
not report key information about the testing procedure, such as the concentration of the taste stimuli,
and these methodological details may have contributed to the range of study results. These different
methods allow stimuli to contact different areas of the oral cavity and tongue (e.g., sensitivity on the
posterior versus anterior tongue), and the delivery method may influence taste perception [45,46].
Because different areas are innervated by different cranial nerves, they may be differentially impacted
by treatment [43,47]. Food-related measures also varied across studies. For those evaluating intake, all
studies used either food-frequency questionnaires or dietary recalls (24-h or 3-day recalls), with the
exception of one weighed food study [23]. Evaluation of food preferences in the four studies used
pictures of foods that were representative of portion sizes and different macronutrients [17,18,27,28],
developed as a measure of food preference based on taste and macronutrient categories [48]. Studies
using this method had mixed results for changes in food preferences during treatment [17,28,49], and
were not associated with objective taste and smell measures [17,18,27,49]. These methods are not
without limitations and may not accurately represent daily intake. Furthermore, food intake was not
always normalized for body weight or accounted for recent weight history. This can be challenging as
recommended caloric intake during cancer treatment may not be reflective their current body weight,
with clinicians modifying patients’ diet to promote weight loss or maintain weight. Overall, it is
recommended that more objective measures be used to quantify food intake [50], notwithstanding the
practical barriers and participant burden inherent in doing so.
4.4. Individual Differences and Genetic Background
Some of the different findings among studies might be due to variation arising from individual
differences in taste perception. A well-studied phenomenon is the wide variation across individuals in
response to the bitterness of propylthiouracil (PTU or PROP) and phenylthiocarbamide (PTC) [51–53].
Some of the variation in response to these bitter compounds and others is linked to genetic differences
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in bitter taste receptor genes (TAS2Rs) [54–60]. Individual differences in perception are associated
with differences in the liking and intake of foods [60–64]. This points to the importance of individual
differences in perception that may result from genetic differences [59,65] (see Hayes et al. [66]) or dietary
exposure [67–70], and is why longitudinal studies are preferred, where the patients act as their own
control. Indeed, there appears to be a link between the genetics of a bitter taste receptor (TAS2R38) and
the risk of developing cancer; however, the direction of this relationship is unclear [71–73]; although the
direct pathophysiology is not known, it is likely driven by factors other than differences in vegetable
and fruit intake [74]. Taken together, greater attention to differences across individuals arising from
taste genotypes is warranted regarding taste studies.
4.5. Translation to Real-World Food Interactions and Clinical Applications
The goal of this review was to determine whether alterations in chemosensory function are
associated with changes in food behavior, including consumption, preference, and enjoyment, in
cancer patients. However, we must consider how changes in taste thresholds (DT or RT) translate
to how we experience food. Threshold measures are variable and subject to false positives [75], and
do not correlate with suprathreshold ratings or hedonic response [33,76,77]. However, the intensity
and hedonic response of suprathreshold stimuli has been associated with the intake of a variety of
foods and beverages [67,68,78,79]. Of the eleven studies included in this review, three presented taste
stimuli at suprathreshold levels [17,21,25], of these studies, two reported a significant relationship
with reduced energy intake [21,25], and another reported no relationship with food preference [17].
Selection of the psychophysical sensory methods is important and the translation of these measures to
food behavior and nutritional status must be taken into consideration. More studies are needed to
evaluate taste function above the detection threshold and how changes in taste perception mediate
dietary intake and food behavior.
Patients should receive information on taste changes prior to treatment; this requires the proper
training of clinicians such that they are equipped with validated evaluation measures. However, there
is no such rapid detection or diagnosis tool that can be administered in a clinical setting. Currently, there
are no clinical guidelines on the assessment or strategies for managing or improving taste problems.
Future work will help to identify whether patient or clinical characteristics are associated with an
increased risk for developing taste alterations, with more work needed to explore the long-term effects
of cancer treatment, whether taste fully recovers, or whether there are long-lasting and persistent
alterations. Another area that needs attention is the taxonomies used to describe alterations in taste
function [15], with disparities being present in the use of the classifications across disciplines. Overall,
more work is needed make diagnostic tools available for clinicians and information available for
patients, along with identifying strategies for the treatment of taste disorders.
5. Conclusions
Taste and smell function related to food behavior in people affected by cancer is understudied
and the mix of positive and negative results may be due to the mix of measurement methods and
experimental designs [3,15,32,80]. However, we can say that among the studies with statistically
significant associations between chemosensory function and food behavior (5 out of the 11 reviewed
here), reduced taste function, particularly for sweet stimuli, was associated with a reduced appetite,
avoidance of certain foods (e.g., meat), and reduced consumption (e.g., overall calories and protein).
Additional studies that use a consistent methodology will better elucidate the duration and extent to
which taste and smell alterations impact patient outcome.
The results of laboratory studies investigating taste and food behavior may have practical
implications. Clinicians lack standardized tools with a high clinical utility to routinely assess and treat
taste and smell disorders in oncology patients. A clearer understanding of the effect of taste and smell
alterations on elements of food behavior may support the design and testing of clinical strategies and
Nutrients 2019, 11, 2285 13 of 17
interventional approaches aimed at mitigating the deleterious effects of chemosensory dysfunction as
a result of cancer treatment.
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